0.0745	3.0778	OMIM:611771	#611771 LIPOPROTEIN GLOMERULOPATHY; LPG	APOE	348
0.1437	2.8953	OMIM:256370	NEPHROTIC SYNDROME, EARLY-ONSET, WITH DIFFUSE MESANGIAL SCLEROSIS	WT1	7490
0.1437	2.6265	OMIM:613237	#613237 FOCAL SEGMENTAL GLOMERULOSCLEROSIS 5; FSGS5;;GLOMERULOSCLEROSIS, FOCAL SEGMENTAL, 5	INF2	64423
0.1437	2.4248	OMIM:614650	#614650 COENZYME Q10 DEFICIENCY, PRIMARY, 6; COQ10D6	COQ6	51004
0.1437	2.4098	OMIM:615244	#615244 NEPHROTIC SYNDROME, TYPE 8; NPHS8	ARHGDIA	396
0.1437	2.4098	OMIM:610725	#610725 NEPHROTIC SYNDROME, TYPE 3; NPHS3;;NEPHROTIC SYNDROME, EARLY-ONSET, TYPE 3	PLCE1	51196
0.1437	2.2662	OMIM:249660	MESANGIAL SCLEROSIS, DIFFUSE RENAL, WITH OCULAR ABNORMALITIES		
0.1437	2.2104	OMIM:609049	PIERSON SYNDROME	LAMB2	3913
0.1437	1.0583	OMIM:231090	HYDATIDIFORM MOLE	NLRP7	199713
0.1437	1.0583	OMIM:305690	GENITOURINARY TRACT ANOMALIES		
0.1437	1.0583	OMIM:600171	GONADAL AGENESIS		
0.1437	1.0583	OMIM:191600	URETER, CANCER OF		
0.1437	1.0583	OMIM:149600	LABIA MINORA, INCOMPLETE ADHESION OF		
0.1437	1.0583	OMIM:191800	URINARY BLADDER, ATONY OF		
0.1639	2.3827	OMIM:603965	#603965 FOCAL SEGMENTAL GLOMERULOSCLEROSIS 2; FSGS2;;GLOMERULOSCLEROSIS, FOCAL SEGMENTAL, 2	TRPC6	7225
0.2048	1.7227	OMIM:218900	CROME SYNDROME		
0.2147	1.8909	OMIM:608104	ALG8-CDG	ALG8	79053
0.2235	2.1329	OMIM:104200	#104200 ALPORT SYNDROME, AUTOSOMAL DOMINANT	COL4A3	1285
0.2392	2.3480	OMIM:611498	#611498 NEPHRONOPHTHISIS 7; NPHP7	GLIS2	84662
0.2607	1.8102	OMIM:160010	%160010 MYOGLOBINURIA, AUTOSOMAL DOMINANT		
